Education
About Us
Working with TipRanks
Follow Us
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
Earnings Data
Report Date
Mar 04, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.38Last Year’s EPS
0.19Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented strong year-over-year growth and operational achievements, such as significant revenue growth, improved margins, and international expansion plans. However, there were also challenges including a seasonal slowdown and sequential revenue decline. The overall sentiment is balanced with more highlights than lowlights.Company Guidance
Significant Year-Over-Year Revenue Growth
Total revenue for Q3 2025 was approximately $144 million, representing a 32.2% growth year-over-year. U.S. transplant revenue was up 32% year-over-year.
Strong Growth in Organ Segments
Year-over-year growth across all organ segments: nearly 41% in liver, approximately 14% in heart, and approximately 5% in lung revenues.
Improved Operating Margins
Operating profit for Q3 was $23.3 million, representing more than 16% of total revenue, up from $3.9 million or approximately 4% of total revenue in Q3 2024.
Cash Position and Cash Generation
The company added approximately $65.6 million of cash to its balance sheet, ending Q3 with over $466.2 million in cash.
International Expansion
Plans to launch the first OUS NOP program in Italy with the establishment of up to 4 hubs, expected to catalyze growth in Europe.
TMDX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TMDX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 29, 2025 | $134.32 | $135.79 | +1.09% |
Jul 30, 2025 | $107.70 | $118.97 | +10.46% |
May 08, 2025 | $93.20 | $111.50 | +19.64% |
Feb 27, 2025 | $72.12 | $76.32 | +5.82% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does TransMedics Group Inc (TMDX) report earnings?
TransMedics Group Inc (TMDX) is schdueled to report earning on Mar 04, 2026, After Close (Confirmed).
What is TransMedics Group Inc (TMDX) earnings time?
TransMedics Group Inc (TMDX) earnings time is at Mar 04, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TMDX EPS forecast?
TMDX EPS forecast for the fiscal quarter 2025 (Q4) is 0.38.